Literature DB >> 24210065

Coamorphous atorvastatin calcium to improve its physicochemical and pharmacokinetic properties.

Ali Shayanfar1, Hamed Ghavimi, Hamed Hamishekar, Abolghasem Jouyban.   

Abstract

PURPOSE: Atorvastatin calcium (ATC) is classified as class II (low solubility and high permeability) compound according to the biopharmaceutical classification system. The amorphous form of ATC possesses higher solubility, dissolution rate, and bioavailability than its crystalline form. Coamorphous drug system is a new and emerging method to prepare stable amorphous forms, in this case leading to the improved stability of ATC in dissolution medium.
METHODS: In this study, coamorphous form of ATC and nicotinamide (ATC-NIC) was prepared from solvent evaporation method and characterized using differential scanning calorimetry (DSC), Fourier transform infrared spectroscopy (FT-IR) and powder X-ray diffraction (PXRD). The intrinsic dissolution rate and solubility of ATC-NIC were determined along with plasma concentrations of ATC using HPLC after oral dosing in rats.
RESULTS: The crystalline ATC was converted to coamorphous form revealing a molecular interaction between ATC and NIC. The intrinsic dissolution rate, solubility and plasma concentration of coamorphous ATC-NIC are higher than those of crystalline ATC. ATC-NIC coamorphous system showed greater solution stability than those reported in the literature for amorphous ATC.
CONCLUSIONS: Coamorphous ATC-NIC has improved physicochemical and pharmacokinetic properties as compared to ATC. This article is open to POST-PUBLICATION REVIEW. Registered readers (see "For Readers") may comment by clicking on ABSTRACT on the issue's contents page.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24210065     DOI: 10.18433/j3xs4s

Source DB:  PubMed          Journal:  J Pharm Pharm Sci        ISSN: 1482-1826            Impact factor:   2.327


  11 in total

Review 1.  Engineering Cocrystals of PoorlyWater-Soluble Drugs to Enhance Dissolution in Aqueous Medium.

Authors:  Indumathi Sathisaran; Sameer Vishvanath Dalvi
Journal:  Pharmaceutics       Date:  2018-07-31       Impact factor: 6.321

Review 2.  Recent Advances in Enhancement of Dissolution and Supersaturation of Poorly Water-Soluble Drug in Amorphous Pharmaceutical Solids: A Review.

Authors:  Qin Shi; Fang Li; Stacy Yeh; Sakib M Moinuddin; Junbo Xin; Jia Xu; Hao Chen; Bai Ling
Journal:  AAPS PharmSciTech       Date:  2021-12-10       Impact factor: 3.246

3.  Co-Amorphous Formation of Simvastatin-Ezetimibe: Enhanced Physical Stability, Bioavailability and Cholesterol-Lowering Effects in LDLr-/-Mice.

Authors:  Shamuha Bahetibieke; Sakib M Moinuddin; Asiya Baiyisaiti; Xiaoang Liu; Jie Zhang; Guomin Liu; Qin Shi; Ankang Peng; Jun Tao; Chang Di; Ting Cai; Rong Qi
Journal:  Pharmaceutics       Date:  2022-06-13       Impact factor: 6.525

4.  Pharmaceutical Co-Crystals, Salts, and Co-Amorphous Systems: A Novel Opportunity of Hot Melt Extrusion.

Authors:  Sagar Narala; Dinesh Nyavanandi; Priyanka Srinivasan; Preethi Mandati; Suresh Bandari; Michael A Repka
Journal:  J Drug Deliv Sci Technol       Date:  2020-11-09       Impact factor: 3.981

5.  Synergistic effect of hydrotrope and surfactant on solubility and dissolution of atorvastatin calcium: screening factorial design followed by ratio optimization.

Authors:  V F Patel; J Sarai
Journal:  Indian J Pharm Sci       Date:  2014 Nov-Dec       Impact factor: 0.975

Review 6.  Co-Amorphous Solid Dispersions for Solubility and Absorption Improvement of Drugs: Composition, Preparation, Characterization and Formulations for Oral Delivery.

Authors:  Anna Karagianni; Kyriakos Kachrimanis; Ioannis Nikolakakis
Journal:  Pharmaceutics       Date:  2018-07-19       Impact factor: 6.321

7.  Dissolution Enhancement of Atorvastatin Calcium by Cocrystallization.

Authors:  Reham Al-Kazemi; Yacoub Al-Basarah; Aly Nada
Journal:  Adv Pharm Bull       Date:  2019-10-24

8.  Physicochemical Characterization of a Co-Amorphous Atorvastatin-Irbesartan System with a Potential Application in Fixed-Dose Combination Therapy.

Authors:  Marcin Skotnicki; Barbara Jadach; Agnieszka Skotnicka; Bartłomiej Milanowski; Lidia Tajber; Marek Pyda; Jacek Kujawski
Journal:  Pharmaceutics       Date:  2021-01-18       Impact factor: 6.321

9.  Conductometric and volumetric studies of atorvastatin in aqueous solution of arginine from 298.15 to 313.15 K.

Authors:  M M R Meor Mohd Affandi; Minaketan Tripathy; A B A Majeed
Journal:  J Adv Pharm Technol Res       Date:  2016 Jul-Sep

10.  Synthesis, characterization, and stability study of desloratadine multicomponent crystal formation.

Authors:  Ahmad Ainurofiq; Rachmat Mauludin; Diky Mudhakir; Sundani Nurono Soewandhi
Journal:  Res Pharm Sci       Date:  2018-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.